You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 11, November 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pediatric Germ Cell and Human Chorionic Gonadotropin—Producing Tumors

Clinical and Laboratory Features

Anna T. Englund, MD; Mitchell E. Geffner, MD; Ronald A. Nagel, MD; Barbara M. Lippe, MD; Glenn D. Braunstein, MD

Am J Dis Child. 1991;145(11):1294-1297.


Abstract

• Germ cell tumors may cause various aberrations in pubertal development. In prepubertal boys, these tumors may secrete human chorionic gonadotropin, resulting in precocious puberty. Human chorionic gonadotropin and {alpha}-fetoprotein are both useful as germ cell tumor markers in the diagnosis and detection of recurrence. Pregnancyspecific β1-glycoprotein, another oncoplacental antigen, has been used as a tumor marker for trophoblastic neoplasms, but not previously for human chorionic gonadotropin—producing tumors associated with precocious puberty. Patients with germ cell tumors may also have abnormal karyotypes. Herein, we describe six male pediatric patients with germ cell tumors and pubertal derangements seen during an 8-year period. We confirm the high incidence of associated sexual precocity, the usefulness of {alpha}-fetoprotein, human chorionic gonadotropin, and pregnancy-specific β1-glycoprotein as tumor markers in the diagnosis and follow-up of these patients, and the occurrence of sex chromosomal abnormalities.

(AJDC. 1991;145:1294-1297)



Author Affiliations

From the Department of Pediatrics, UCLA Medical Center (Drs Englund, Geffner, Nagel, and Lippe) and the Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, Calif (Dr Braunstein).


Footnotes

Accepted for publication June 3, 1991.

Reprint requests to Department of Pediatrics, UCLA Medical Center, MDCC 22-315,10833 Le Conte, Los Angeles, CA 90024 (Dr Englund).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Balanced Translocation of 10q and 13q, Including the PTENGene, in a Boy with a Human Chorionic Gonadotropin-Secreting Tumor and the Bannayan-Riley-Ruvalcaba Syndrome
J. Clin. Endocrinol. Metab. 1999;84:4665-4670.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.